Alpharma Sues Purdue Over Painkiller Mktg. Rights

Law360, New York (November 18, 2008, 12:00 AM EST) -- Alpharma Inc. has filed a preemptive lawsuit against Purdue Pharma LP, the makers of Oxycontin, over the right to market ALO-01, an opioid painkiller with less potential for abuse.

The lawsuit, filed in the U.S. District Court for the Western District of Virginia, seeks a declaration of invalidity for Purdue patents and judgments of noninfringement for ALO-01, a new opioid drug made by Alpharma that Purdue says infringes its patents.

Alpharma developed ALO-01 because of high rates of prescription drug abuse, the complaint said. Over 15.1...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.